Overview

PDA's 4th Annual Global Conference on Pharmaceutical Microbiology will bring together all levels of industry professionals to network and benefit from a program that demystifies the underlying science of microbiology and seeks to solve the problems that our industry faces on a daily basis. The comprehensive program agenda will include presentations from regulatory and industry representatives from around the world who will share recent case studies and current trends in the field of pharmaceutical microbiology.

During the conference, PDA will host an exhibition of leading bio/pharmaceutical companies who will showcase new technologies and trends for pharmaceutical microbiology strategies.

To complement what you learn at the conference, the PDA Training and Research Institute (PDA TRI) will host training courses on October 8 to expand your knowledge of pharmaceutical microbiology.

Who Should Attend

Departments: Microbiology, Compliance, Engineering, Manufacturing, QA/QC, Development, Regulatory Affairs, Research and Development, Validation
Level of Expertise: Executives, Management, Scientists/Technicians
Job Function: Scientist/Technician, Research, Analyst, Bench personnel

Learning Objectives

At the completion of this program, participants will be able to:

• Describe the role of microbiology in Quality by Design, including managing microbial risk, microbial contamination control and risk management in aseptic processing/manufacturing
• Identify current trends in environmental monitoring and the economic aspect of microbiology ("lean laboratories" and the Return on Investment for Rapid Microbiology Methods)
• Implement appropriate strategies for maintaining a non-sterile manufacturing environment (the importance of microbial identification, testing for and understanding the impact of objectionable organisms, and resolving microbial challenges associated with non-sterile operations)
• Summarize new advances in rapid microbiological methods, microbial identification technologies, endotoxin testing and the use of statistics during data review and validation activities
• Explain the elements of a sterility test failure investigation
• Identify local regulatory and pharmacopeial expectations

Contact

Conference inquiries:
Wanda Neal, Vice President, Programs and Registration Services
Tel: +1 (301) 656-5900 ext. 111
Email: neal@pda.org

Registration inquiries:
Patresa Day, Assistant Manager of Registration and Customer Service
Tel: +1 (301) 656-5900 ext. 115
Email: day@pda.org